| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Loss before income taxes | -3,101 | - | ||
| Provision for income taxes | 202 | - | ||
| Net loss | -3,303 | -16,643 | ||
| Net loss attributable to common stockholders | -3,303 | -16,643 | ||
| Earnings per share, basic | -0.08 | -0.4 | ||
| Earnings per share, diluted | -0.08 | -0.4 | ||
| Weighted average number of shares outstanding, basic | 41,444,979 | 41,444,979 | ||
| Weighted average number of shares outstanding, diluted | 41,444,979 | 41,444,979 | ||
LEAP THERAPEUTICS, INC. (LPTX)
LEAP THERAPEUTICS, INC. (LPTX)